Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8979
|
pubmed:dateCreated |
1995-10-27
|
pubmed:abstractText |
Paraoxonase is a high-density-lipoprotein-associated enzyme capable of hydrolysing lipid peroxides. Thus it might protect lipoproteins from oxidation. It has two isoforms, which arise from a glutamine (A isoform) to arginine (B isoform) interchange at position 192. The relevance of this polymorphism to coronary heart disease (CHD) in non-insulin-dependent diabetic patients was investigated in case-control study. Of the 434 patients, 171 had confirmed coronary artery disease; the other 263 had no history of such disease. The B allele and AB+BB genotypes were associated with an increased risk of coronary heart disease. Compared with subjects homozygous for the A allele (AA genotype), the odds ratio of CHD for subjects homozygous for the B allele was 2.5 (95% CI 1.2-5.3) and that for those heterozygous for the B allele was 1.6 (95% CI 1.1-2.4), suggesting a codominant effect on cardiovascular risk. When subjected to multivariate analysis, the B allele remained significantly associated with CHD (odds ratio 1.94, p = 0.03). The paraoxonase gene polymorphism is thus an independent cardiovascular risk factor in non-insulin-dependent diabetic patients. A possible explanation for this finding is that activity of the paraoxonase B isotype does not protect well against lipid oxidation, a major atherogenic pathway.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
346
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
869-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7564671-Arginine,
pubmed-meshheading:7564671-Aryldialkylphosphatase,
pubmed-meshheading:7564671-Case-Control Studies,
pubmed-meshheading:7564671-Coronary Disease,
pubmed-meshheading:7564671-Diabetes Mellitus, Type 2,
pubmed-meshheading:7564671-Esterases,
pubmed-meshheading:7564671-Female,
pubmed-meshheading:7564671-Genotype,
pubmed-meshheading:7564671-Glutamine,
pubmed-meshheading:7564671-Humans,
pubmed-meshheading:7564671-Male,
pubmed-meshheading:7564671-Middle Aged,
pubmed-meshheading:7564671-Polymorphism, Genetic,
pubmed-meshheading:7564671-Regression Analysis,
pubmed-meshheading:7564671-Risk Factors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
|
pubmed:affiliation |
Division d'Epidémiologie Clinique, Geneva University Hospital, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|